BDBM72982 MLS001028713::N'-(4-fluorophenyl)sulfonyl-N-(1-naphthalenyl)benzenecarboximidamide::N'-(4-fluorophenyl)sulfonyl-N-(1-naphthyl)benzamidine::N'-(4-fluorophenyl)sulfonyl-N-naphthalen-1-yl-benzenecarboximidamide::N'-(4-fluorophenyl)sulfonyl-N-naphthalen-1-ylbenzenecarboximidamide::SMR000634055::cid_5837675

SMILES CN(C(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)C2(C)C)[C@H](C#N)CC1C(=O)Nc2ccccc21

InChI Key InChIKey=FBUBFNPJRYRPSL-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72982   

TargetReplicase polyprotein 1ab(2019-nCoV)
Trawsfynydd Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 72982BDBM72982((1S,2S,5S)-N-[(1S)-1-cyano-2-(2-oxoindolin-3-yl)et...)
Affinity DataIC50: 75nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2026
Entry Details
US Patent